Strides Pharma Science LtdNSE: STAR

Press Release Sep 14 2023

Sep 14, 2023 at 9:05 PM UTC

Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 14, 2023, titled "Strides receives tentative USFDA approval for Dolutegravir tablets".

View Attachment